article thumbnail

Sarcopenia and aortic valve disease

Heart BMJ

Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR).

article thumbnail

Impact of cardiac rehabilitation on pre- and post-operative transcatheter aortic valve replacement prognoses

Frontiers in Cardiovascular Medicine

Transcatheter aortic valve replacement (TAVR) is a relatively new treatment method for aortic stenosis (AS) and has been demonstrated to be suitable for patients with varying risk levels.

article thumbnail

Long Term Survival and Quality of Life Following Transcatheter Aortic Valve Replacement in Nonagenarians

The American Journal of Cardiology

Publication date: Available online 21 December 2023 Source: The American Journal of Cardiology Author(s): Luai Madanat, Mohamed Allam, Houman Khalili, Andrew Rabah, Rehan Tariq, Mazen Zamzam, Josep Rodés-Cabau, Thomas Pilgrim, Taishi Okuno, Sammy Elmariah, Philippe Pibarot, Amr E.

article thumbnail

Medtronic Receives CE Mark for Transcatheter Pulmonary Valve Replacement System

DAIC

mid-term (three-year) data results demonstrated superior patient outcomes with positive sustained RV remodeling, effective valve function, and a strong safety profile, all contributing to significant improvement in patient quality of life. Harmony TPV U.S. For more information, please visit www.Medtronic.com. 1 Hoffman JL, Kaplan S.

article thumbnail

Cardiawave is Presenting the 30-day Follow-up Results from its “Valvosoft Pivotal Study” on the Teatment of Severe Symptomatic Aortic Valve Stenosis at ACC24

DAIC

Presentation title: QUALITY OF LIFE ASSESSMENT AT 30-DAYS FOLLOW-UP OF THE VALVOSOFT PIVOTAL STUDY ON SEVERE AORTIC VALVE STENOSE PATIENTS" (control number 16930) Time and date: April 8, 2024 - 9:32 a.m.–9:42 A summary of the poster session will be published on the Journal of the American College of Cardiology’s website.

article thumbnail

Transcatheter aortic valve replacement in heart failure

European Journal of Heart Failure

ABSTRACT Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes. The use of transcatheter aortic valve replacement (TAVR) has become the preferred therapy for most patients with AS and concomitant HF.

article thumbnail

Health Care Cost and Resource Utilization After Aortic Valve Replacement According to the Extent of Cardiac Damage

Circulation: Cardiovascular Interventions

BACKGROUND:The extent of cardiac damage has been shown to be associated with increased mortality, repeat hospitalization, and decreased quality of life after aortic valve replacement (AVR).